AZURECELL
LIVE

Serial Number

79448144

Owner

AZURECELL SA

Filing Date

Jan 14, 2026

Add to watchlist:

No watchlists yet
View on USPTO

AZURECELL Trademark

Serial Number: 79448144

AZURECELL is a trademark filed by AZURECELL SA on January 14, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

AZURECELL SA

Avenue de la Roseraie 64

Entity Type: 98

Trademark Details

Filing Date

January 14, 2026

Registration Date

Not Registered

Goods & Services

Medical services; regenerative medicine services; cultured cell bank services for medical transplantation; medical treatment services by means of cultured cells; medical treatment services by means of cell therapy; preparation, expansion and characterization of cells for therapeutic purposes; clinical advice on cell therapy; genetic analysis services for medical use.

Scientific and technological services as well as research and design services relating thereto; scientific and technological services in the field of cell therapy; scientific and technological services in the field of genetic engineering; genetic engineering services; scientific and technological services in the field of brain and nervous system conditions; scientific and technological services in the field of neuroregenerative medicine and neurobiology; synthetic biology research and development; design, especially assisted by artificial intelligence, of therapeutic proteins; development and validation of production processes for cell therapy agents for quality or standards certification; design and development of tests to identify, quantify, analyze, and validate biomarkers in the field of brain or nervous system degeneration; bioinformatics-based medical data analysis services in the field of brain or nervous system degeneration.

Biological preparations other than for medical or veterinary use; stem cells other than for medical or veterinary use; non-stem cells other than for medical or veterinary use; cell culture reagents, matrices and media other than for medical or veterinary use; cell lines for scientific use; molecular genetics reagents, plasmids, and vectors for scientific use.

Pharmaceutical products, medical and veterinary preparations; pharmaceutical preparations for activating cellular functions; medical preparations for the treatment of the brain and nervous system, including neurodegenerative diseases and movement disorders; medical preparations for the treatment of Parkinson's disease; biotechnological preparations for medical use; biotechnological preparations for gene or cell therapy; cells for medical use; living cells and living tissues for medical use; theranostic therapeutic cells; surgical implants consisting of living tissues and cells; chemical or biological reagents and culture media for medical use; diagnostic agents for medical use; diagnostic kits for medical use.

Filing History

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 20, 2026 RFCR
NON-FINAL ACTION WRITTEN
May 19, 2026 CNRT
ASSIGNED TO EXAMINER
May 12, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 22, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 22, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 16, 2026 REPR